SEC Case Against Musk Over Twitter Stake Heads to Trial

Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal Definium Therapeutics shares surged as much as 54% on Monday, reaching $37.90 in morning trading as investors reacted positively to developments in the biotech company's research pipeline and potential strategic opportunities. Definium Therapeutics said its LSD-based depression drug, DT120, met the main goal of a mid-stage trial, reducing depression scores by 8.1 points more than placebo after six weeks, according to Reuters. Patients showed improvement within one week after a single dose, with benefits remaining at 12...

US Africa Command said on Tuesday that its forces launched airstrikes in northeastern Nigeria on May 18, marking the third day in a row that the US conducted strikes in the West African nation. AFRICOM said the latest strikes were launched in coordination with the Nigerian government and claimed that the targets of the strikes […]

UCLA Medical School Accused Of Racial Discrimination In Defiance Of Supreme Court Authored by Jonathan Turley, We previously discussed a disturbing account of how medical students at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) were subjected to a bizarre class where one of the university’s “activists-in-residence” showered them with anti-Semitic postings and racist rhetoric. Now, the Justice Department has found that the university engaged in systemic racial discrimination in the admission of medical students. Given the university’s history, it is hardly surprising, but it remains unclear...